• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Delcath Systems, Inc. - Common Stock (NQ: DCTH )

    11.86 -0.11 (-0.92%)
    Streaming Delayed Price Updated: 2:32 PM EST, Dec 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 111,524
    Open 11.89
    Bid (Size) 11.83 (5)
    Ask (Size) 11.88 (14)
    Prev. Close 11.97
    Today's Range 11.42 - 11.99
    52wk Range 3.700 - 13.30
    Shares Outstanding 7,906,728
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    MicroStrategy, Portland General Electric And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Thursday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Zoomcar Shares Are Trading Higher By Around 142%; Here Are 20 Stocks Moving Premarket
    Via Benzinga

    Performance

    YTD
    +188.92%
    +188.92%
    1 Month
    +11.36%
    +11.36%
    3 Month
    +33.71%
    +33.71%
    6 Month
    +44.11%
    +44.11%
    1 Year
    +192.12%
    +192.12%

    More News

    Read More
    Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer
    From Delcath Systems, Inc.
    Via Business Wire
    Uncovering Potential: Delcath Systems's Earnings Preview
    Via Benzinga
    Analyst Scoreboard: 4 Ratings For Delcath Systems
    Via Benzinga
    Assessing Delcath Systems: Insights From 4 Financial Analysts
    Via Benzinga
    Delcath Systems Reports Third Quarter 2024 Results and Business Highlights
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems to Participate in Upcoming Investor Conferences
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems to Host Third Quarter 2024 Earnings Call
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KIT™ in Metastatic Uveal Melanoma Subgroups
    From Delcath Systems, Inc.
    Via Business Wire
    'This Is A Very Speculative Situation,' Jim Cramer On ADMA Biologics
    Via Benzinga
    Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems, Inc. Announces Promising Results from Independent Study on Repeated Hepatic Chemosaturation for Liver Tumors
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems Announces Poster Presentation at the 2024 ESMO Congress
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Delcath Systems, Inc.
    Via Business Wire
    DCTH Stock Earnings: Delcath Systems Misses EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Delcath Systems Reports Second Quarter 2024 Results and Business Highlights
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems Announces CMS Approval for NTAP for HEPZATO KIT™
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems to Participate in Upcoming Investor Conferences
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems to Host Second Quarter 2024 Earnings Call
    From Delcath Systems, Inc.
    Via Business Wire
    Have $5-10? 7 Affordable Stocks That Are About to Breakout.
    Via InvestorPlace
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.